Literature DB >> 28217754

N staging system: tumor-node-metastasis and future perspectives.

Federica Galli1, Laura Ruspi1, Alessandro Marzorati1, Matteo Lavazza1, Giuseppe Di Rocco1, Luigi Boni1, Gianlorenzo Dionigi1, Stefano Rausei1.   

Abstract

The correct staging of disease, with an exact definition of the extent of cancer at the diagnosis, is crucial in the planning of a specific treatment and in the assessment of real chances of cure. Cancer staging systems are expected to be accurate in the description of the severity of a patient's tumor on the basis of the extent of the primary neoplasm and of its spread, thus giving clinician tools to estimate prognosis and providing objective parameters to compare groups of patients in clinical studies. This last point is of wide importance in evaluating successful treatment strategies in oncology, and this is one of the issues that contributed to the development of stage-adapted therapies.

Entities:  

Keywords:  Tumor-node-metastasis staging system (TNM staging system); gastric cancer staging; lymph node in gastric cancer

Year:  2017        PMID: 28217754      PMCID: PMC5313289          DOI: 10.21037/tgh.2017.01.03

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  17 in total

1.  Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection.

Authors:  Zhe Sun; Yan Xu; De Ming Li; Zhen Ning Wang; Guo Lian Zhu; Bao Jun Huang; Kai Li; Hui Mian Xu
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

2.  Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.

Authors:  Bao-Yan Zhang; Jing Yuan; Zhen-Shuang Cui; Zhong-Wu Li; Xiang-Hong Li; You-Yong Lu
Journal:  Am J Surg       Date:  2013-10-12       Impact factor: 2.565

3.  Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

4.  Locally advanced gastric cancer: a new definition to standardise.

Authors:  Stefano Rausei; Luigi Boni; Francesca Rovera; Gianlorenzo Dionigi
Journal:  J Clin Pathol       Date:  2012-12-08       Impact factor: 3.411

5.  Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.

Authors:  Jiping Wang; Ping Dang; Chandrajit P Raut; Prakash K Pandalai; Ugwuji N Maduekwe; David W Rattner; Gregory Y Lauwers; Sam S Yoon
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

6.  Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Authors:  Hye Seong Ahn; Hyuk-Joon Lee; Seokyung Hahn; Woo-Ho Kim; Kuhn Uk Lee; Takeshi Sano; Stephen B Edge; Han-Kwang Yang
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

Review 7.  Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011.

Authors:  Stefano Rausei; Gianlorenzo Dionigi; Takeshi Sano; Mitsuru Sasako; Alberto Biondi; Paolo Morgagni; Alfredo Garofalo; Luigi Boni; Francesco Frattini; Domenico D'Ugo; Shaun Preston; Daniele Marrelli; Maurizio Degiuli; Carlo Capella; Rosario Sacco; Laura Ruspi; Giovanni De Manzoni; Franco Roviello; Graziella Pinotti; Francesca Rovera; Sung Hoon Noh; Daniel Coit; Renzo Dionigi
Journal:  Ann Surg Oncol       Date:  2013-07-10       Impact factor: 5.344

8.  Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients.

Authors:  W Wang; D Z Xu; Y F Li; Y X Guan; X W Sun; Y B Chen; R Kesari; C Y Huang; W Li; Y Q Zhan; Z W Zhou
Journal:  Ann Oncol       Date:  2011-02-10       Impact factor: 32.976

9.  The evaluation of metastatic lymph node ratio staging system in gastric cancer.

Authors:  Yanbing Zhou; Jizhun Zhang; Shougen Cao; Yu Li
Journal:  Gastric Cancer       Date:  2012-09-04       Impact factor: 7.370

10.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more
  1 in total

1.  Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women.

Authors:  Magdy M Youssef; Afaf M Elsaid; Rasha A El-Saeed; Riyadh T Mukhlif; Hisham Megahed; Adel I Al-Alawy; Rami M Elshazli
Journal:  Biochem Genet       Date:  2021-05-03       Impact factor: 1.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.